Resveratrol induces apoptosis in LNCaP cells and requires hydroxyl groups to decrease viability in LNCaP and DU 145 cells

Prostate

Volumn 52, Issue 4, 2002, Pages 319-329

  Morris, Gary Z ^a,b   Williams, Roy L ^a,b   Elliott, Mark S ^a,b   Beebe, Stephen J ^a,b  

^a OLD DOMINION UNIVERSITY   (United States)

^b CENTER FOR PEDIATRIC RESEARCH   (United States)

Author keywords

Annexin V FITC; Apoptotic morphology; Diethylstilbestrol (DES); Hormone responsive prostate cancer; Trans resveratrol (TR); Tri methoxy resveratrol (TmTR)

Indexed keywords

CASPASE; DIETHYLSTILBESTROL; FLUORESCEIN ISOTHIOCYANATE; HYDROXYL GROUP; LIPOCORTIN 5; PHYTOESTROGEN; RESVERATROL; TRIMETHOXYRESVERATROL; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CELL VIABILITY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER;

ANTINEOPLASTIC AGENTS, HORMONAL; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CASPASES; CELL SURVIVAL; DIETHYLSTILBESTROL; ESTROGENS, NON-STEROIDAL; HUMANS; HYDROXYL RADICAL; MALE; PROSTATIC NEOPLASMS; STILBENES; TUMOR CELLS, CULTURED;

EID: 0036720648     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/pros.10122     Document Type: Article

References (50)

1. Phyto-estrogens and western diseases
2. International trends and patterns of prostate cancer incidence and mortality
3. The epidemiology of prostate cancer. II. The risk factors
4. Resveratrol: A molecule whose time has come? And gone?
5. Biological effects of resveratrol
6. Trans-resveratrol content in commercial peanuts and peanut products
7. Occurrence of resveratrol in edible peanuts
8. Current concepts in the treatment of cancer of the prostate
9. Chemopreventive agent resveratrol, a natural product derived from grapes triggers CD 95 signaling dependent-apoptosis in human tumor cells
10. Differential effects on growth, cell cycle arrest, and induction of apoptosis by resveratrol in human prostate cancer cell lines
11. Diethylstilbestrol in the prevention and treatment of complications of pregnancy
12. A phase II trial of oral diethylstilbestrol as a second-line hormonal agent in advanced prostate cancer
13. Estrogens in the treatment of prostate cancer
14. Induction of apoptosis by diethylstilbestrol in hormone-insensitive prostate cancer cells
15. Cellular interaction in prostate cancer
16. Aberrant response in vitro of hormone-responsive prostate cancer cells to antiandrogens
17. A mutation in the ligand-binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens
18. Expression and function of normal and LNCaP androgen receptors in androgen-insensitive human prostatic cancer cells. Altered hormone andantihormone specificity in gene transactivation
19. The LNCaP cell line-a new model for studies on human prostatic carcinoma
20. Cell death: The significance of apoptosis
21. The biology of cell death in tumors
22. Cell death
23. Apoptosis: Mechanisms and roles in pathology
24. Apoptosis-molecular mechanisms and biomedical implications
25. Mechanisms of apoptosis and its potential role in renal tubular epithelial cell injury
26. Type I cAMP-dependent protein kinase delays apoptosis in human neutrophils and a site upstream of caspase-3
27. Annexin V used for measuring apoptosis in the early events of cellular cytotoxicity
28. A comparative study of different methods for the assessment of apoptosis and necrosis in human eosinophils
29. Critical evaluation of techniques to detect and measure cell death: Study in a model of UV radiation of the leukaemic cell line HL60
30. Caspases and caspase inhibitors
31. Biochemical characteristics of caspases-3, -6, -7 and -8
32. Determination of caspase specificities using a peptide combinatorial library
33. Characterization of human prostate adenocarcinoma cell line (DU 145) as a monolayer culture and as a solid tumor in athymic mice
34. Caspases: Enemies within
35. Resveratrol arrests the cell division cycle at S/G2 phase transition
36. Death receptors: Signaling and modulation
37. Mitochondria and apoptosis
38. A matter of life and cell death
39. Fas-mediated apoptosis in human prostate carcinoma cell line
40. Chemosensitization of human prostate carcinoma cell lines to anti-fas-mediated cytotoxic and apoptosis
41. p53 oncogene mutations in three human prostate cancer cell lines
42. Prostate cancer cell growth inhibition by tamoxifen is associated with inhibition of protein kinase C and inhibition of p21waf/cip I
43. Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamox ifen isomers in MCF-7 human breast cancer cells
44. Expression of estrogen receptor (ER-alpha and ER-beta) mRNA in human prostate cancer
45. Cloning of a novel receptor expressed in rat prostate and ovary
46. Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor
47. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models
48. The cancer chemopreventive agent resveratrol is incorporated into model membranes and inhibits protein kinase C? activity
49. Kinase inhibitors from Polygonum Cuspidatum
50. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes